Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Giulia Maggioni et al.|Journal of Clinical Oncology|2023Cited by 109
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Gastone Castellani, Manja Meggendorfer et al.|Blood|2021Cited by 72
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort studyGiulia Maggioni, Uwe Platzbecker, Matteo Bersanelli et al.|The Lancet Haematology|2022Cited by 34
Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Torsten Haferlach et al.|Blood|2022Cited by 4